Davita Healthcare Partners Inc
(DVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 605,732 | 305,980 | 956,978 | 726,406 | 417,045 |
| Depreciation Amortization | 362,744 | 187,083 | 745,443 | 550,166 | 361,743 |
| Income taxes - deferred | -28,643 | -3,318 | -39,354 | -17,767 | -16,178 |
| Accounts receivable | -193,093 | -561,281 | 172,361 | 118,148 | 141,503 |
| Accounts payable and accrued liabilities | -38,998 | -14,162 | 26,890 | -33,837 | -40,615 |
| Other Working Capital | -363,271 | -640,146 | 194,535 | 183,822 | 78,314 |
| Other Operating Activity | 319,539 | 591,008 | 2,178 | 46,888 | -29,148 |
| Operating Cash Flow | $664,010 | $-134,836 | $2,059,031 | $1,573,826 | $912,664 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 844 | -2,984 | 63,258 | 57,302 | -32,912 |
| PPE Investments | -232,961 | -113,975 | -567,985 | -409,011 | -251,006 |
| Net Acquisitions | -157,783 | -105,163 | -26,394 | 16,917 | -2,575 |
| Purchase Of Investment | 6,382 | -460 | -276,202 | -276,006 | -178,922 |
| Sale Of Investment | N/A | 4,547 | N/A | 3,930 | N/A |
| Purchase Sale Intangibles | N/A | N/A | 30,610 | N/A | N/A |
| Other Investing Activity | 6,554 | 2,829 | 35,523 | 3,364 | 1,758 |
| Investing Cash Flow | $-376,964 | $-215,206 | $-771,800 | $-603,504 | $-463,657 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,275,533 | 1,290,255 | 2,468,341 | 2,468,335 | 2,136,873 |
| Debt Repayment | -2,661,145 | -554,544 | -3,020,956 | -2,992,248 | -2,347,120 |
| Common Stock Issued | 7,421 | 4,143 | 16,900 | -41,155 | -43,612 |
| Common Stock Repurchased | -612,614 | -250,961 | -272,219 | 0 | N/A |
| Other Financing Activity | -253,171 | -169,574 | -362,561 | -202,181 | -118,889 |
| Financing Cash Flow | $-243,976 | $319,319 | $-1,170,495 | $-767,249 | $-372,748 |
| Exchange Rate Effect | -4,458 | -3,130 | 8,909 | 3,063 | 6,922 |
| Beginning Cash Position | 464,634 | 464,634 | 338,989 | 338,989 | 338,989 |
| End Cash Position | 503,246 | 430,781 | 464,634 | 545,125 | 422,170 |
| Net Cash Flow | $38,612 | $-33,853 | $125,645 | $206,136 | $83,181 |
| Free Cash Flow | |||||
| Operating Cash Flow | 664,010 | -134,836 | 2,059,031 | 1,573,826 | 912,664 |
| Capital Expenditure | -245,740 | -121,015 | -567,985 | -409,011 | -272,204 |
| Free Cash Flow | 418,270 | -255,851 | 1,491,046 | 1,164,815 | 640,460 |